title: CORDIO
description: "# CORDIO
CORDIO is a biotechnology company focused on developing disease-modifying therapies for neurodegenerative diseases, particularly tauopathies including PSP and Alzheimer's disease.
CORDIO is developing small molecules that:
The company has several programs in preclinical development targeting various aspects of tau pathology.
CORDIO focuses on developing novel small molecule inhibitors of:
As a company specifically focused on tauopathies, CORDIO's programs are directly relevant to PSP: